Inventor
CHOREV MICHAEL
IL37 patents
⚠️ This page may combine multiple inventors who share the name “CHOREV MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
YISSUM RES DEV CO
8 patentsUS5217999AJun 8, 1993
Styryl compounds which inhibit EGF receptor protein tyrosine kinase
YISSUM RES DEV CO302 citations99
US6462222B1Oct 8, 2002
Aminoindan derivatives
YISSUM RES DEV CO82 citations97
US6303650B1Oct 16, 2001
Aminoindan derivatives
YISSUM RES DEV CO58 citations95
US6479460B1Nov 12, 2002
Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same
YISSUM RES DEV CO16 citations89
US5814610ASep 29, 1998
Osteogenic growth oligopeptides and pharmaceutical compositions containing them
YISSUM RES DEV CO21 citations88
US5461034AOct 24, 1995
Osteogenic growth polypeptides identified from regenerating bone marrow
YISSUM RES DEV CO44 citations88
USRE38761EJul 19, 2005
Styryl compounds which inhibit EGF receptor protein tyrosine kinase
YISSUM RES DEV CO13 citations84
US7189692B2Mar 13, 2007
Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same
YISSUM RES DEV CO1 citations49
MERCK & CO INC
8 patentsUS4968669ANov 6, 1990
Parathyroid hormone antagonists
MERCK & CO INC55 citations96
US4771124ASep 13, 1988
Parathyroid hormone antagonists with simplified synthetic methodology
MERCK & CO INC59 citations93
US5093233AMar 3, 1992
Antagonists with position 13 modification
MERCK & CO INC43 citations91
US5001223AMar 19, 1991
Parathyroid hormone antagonists with enhanced metabolic properties
MERCK & CO INC36 citations91
US5149779ASep 22, 1992
Humoral hypercalcemic factor antagonists
MERCK & CO INC24 citations86
US5087562AFeb 11, 1992
Humoral hypercalcemic factor antagonists with modification at position 13 . . .
MERCK & CO INC18 citations81
US5242680ASep 7, 1993
Thiol-reactive maleimido-based radiolabeling reagents
MERCK & CO INC12 citations74
US5087561AFeb 11, 1992
Humoral hypercalcemic factor antagonists modified at position 13 by biotin
MERCK & CO INC5 citations61
HARVARD COLLEGE
6 patentsUS11161910B2Nov 2, 2021
Glycated CD59 peptides, their preparation, and uses thereof
HARVARD COLLEGE2 citations73
US11891448B2Feb 6, 2024
Glycated CD59 peptides, their preparation, and uses thereof
HARVARD COLLEGE0 citations62
US10309973B2Jun 4, 2019
Surrogates of post-translationally modified proteins and uses thereof
HARVARD COLLEGE0 citations52
US9932300B2Apr 3, 2018
N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation
HARVARD COLLEGE0 citations47
US10732186B2Aug 4, 2020
Methods and reagents for the assessment of gestational diabetes
HARVARD COLLEGE0 citations42
US9952200B2Apr 24, 2018
Cell based quality control bioassays for nutriceutical and medicinal products
HARVARD COLLEGE0 citations41
CHOREV MICHAEL
3 patentsUS7799757B2Sep 21, 2010
Analogs of parathyroid hormone and PTH-related protein as bone anabolic agents
CHOREV MICHAEL7 citations72
US9417248B2Aug 16, 2016
Surrogates of post-translationally modified proteins and uses thereof
CHOREV MICHAEL4 citations71
US8969573B2Mar 3, 2015
Compounds for the inhibition of cellular proliferation
CHOREV MICHAEL0 citations49